# Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants

> **NCT01544972** · PHASE4 · UNKNOWN · sponsor: **Zekai Tahir Burak Women's Health Research and Education Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Patent Ductus Arteriosus

## Interventions

- **DRUG:** Oral paracetamol
- **DRUG:** Oral ibuprofen

## Key facts

- **NCT ID:** NCT01544972
- **Lead sponsor:** Zekai Tahir Burak Women's Health Research and Education Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2012-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01544972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01544972, "Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01544972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*